tirzepatide or glp 1 GLP-1/GIP Rx Effects of tirzepatide, a dual

Although both act on the GLP-1 pathway to stimulate insulin release, slow stomach emptying, and reduce appetite, they were developed with different target populations in mind

When used with insulin or sulfonylureas, it can cause low blood sugar levels

Updates on obesity and the obesity paradox in cardiovascular diseases

Weight alone does not tell the full story because you might lose fat while maintaining or gaining muscle, resulting in minimal scale movement despite significant body composition improvement

These symptoms may intensify if tirzepatide is introduced at too high a dose or without proper titration

Completely different markings on the syringe